Report Overview

Indian Oral Anti- Diabetic Drugs market size stood at USD XX Billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast period 2019-2028.

Diabetes is rapidly gaining the status of a potential epidemic in India with around 65 million people currently being affected by it.Diabetes is rapidly gaining the status of a potential epidemic in India with around 65 million people currently being affected by.The

Market Drivers

The heightening obesity rates, rising stress levels, lack of proper exercise, adoption of sedentary lifestyle, increase in consumption of unhealthy diet, increase in the healthcare expenditures, growing prevalence of diabetes, increased demand of therapeutic drugs, the market for Oral Anti- Diabetic Drugs and diagnostics is expanding robustly in India. In order to control the damage caused by the increasing cases of diabetes in the country, the Indian Government is taking initiatives to provide free treatment and insulin to diabetics at government hospitals. Some of the other factors contributing to the market growth are rapid urbanization, developing healthcare infrastructure, low-cost of drug production, accelerating pharmaceutical contract manufacturing and introduction of advanced technologies.